Source study found
Story checked
New NHS-ready medication risk tool could cut falls and delirium in older people (opens in a new tab)
medicalxpress.com · 2026-11-05
Short answer
Not assessedCheck incomplete.
We found a likely source study, but its evidence could not be prepared for claim review. The article's claims remain unverified.
Share this check
Help improve NewsLink
Tell us what worked or what needs attention in this check.
The story
New NHS-ready medication risk tool could cut falls and delirium in older people
medicalxpress.com · 2026-11-05
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Source study identified.
A source study was identified, but the study's evidence could not be prepared for claim assessment. No claim verdicts are available.
View article claimsThe source study
Deriving the anticholinergic medication index for delirium and falls in older people: development and external validation of a risk prediction model
Evidence layer
Claim by claim
A source study was identified, but the study's evidence could not be prepared for claim assessment. The claims below have not been assessed.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedResearchers have developed a new tool to help doctors and pharmacists identify older patients at risk of delirium and serious falls associated with taking multiple anticholinergic medications.View evidenceHide evidence
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 2 of 5Not checkedThe Anticholinergic Medication Index (ACMI) scores a patient's anticholinergic burden based on the risk of delirium or falls and is designed to be embedded into electronic patient record systems.View evidenceHide evidence
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 3 of 5Not checkedThe tool was piloted in general practitioners' offices in Bradford to automatically generate lists of patients aged 65 and older, their ACMI scores, the medicines contributing to those scores, and their one-year predicted risk of a fall or delirium.View evidenceHide evidence
As statedone-year predicted risk
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 4 of 5Not checkedThe ACMI was developed and tested using health data from nearly 750,000 adults aged over 65 years and then tested in a national dataset from Wales.View evidenceHide evidence
As statednearly 750,000 adults aged over 65 years
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 5 of 5Not checkedA related tool, ACMICS, has been embedded directly within hospital electronic patient record systems at two NHS trusts and is now live and in use.View evidenceHide evidence
As statedtwo NHS trusts
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Deriving the anticholinergic medication index for delirium and falls in older people: development and external validation of a risk prediction model
BMJ medicine · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
PubMed, Crossref, Europe PMC · 38 candidate papers
Deriving the anticholinergic medication index for delirium and falls in older people: development and external validation of a risk prediction model
BMJ Medicine · 2026 · PubMed, Crossref
Selecting the best..from the best - Part II
2026 · Crossref
National survey of perinatal professionals' experiences and approaches to conducting prebirth periviable (22+0 to 23+6 weeks) conversations: a mixed-methods study.
2026 · Europe PMC
Selecting the best..from the best - Part I
2026 · Crossref
Exploration of best practices in the creation and dissemination of video vignettes in mental healthcare training: a qualitative analysis of multiple stakeholder perspectives across US psychosis services.
2026 · Europe PMC
Effectiveness and safety of treatments for new-onset, refractory and relapsed vitreoretinal lymphoma: protocol for a systematic review and network meta-analysis.
2026 · Europe PMC
And 32 more candidates considered.